It’s not just money that is lacking. Successful development of medical therapeutics in Japan ー including vaccines ー takes transparency and ethical policies.
iPS cells bring hope for treatment of neurodegenerative diseases such as Parkinson’s, but China and the US are ahead in bringing Japan’s discovery to practical use.
